Barclays Downgrades Regenxbio Inc. (RGNX) to Equalweight

August 7, 2026 3:32 AM

Barclays analyst Eliana Merle downgraded Regenxbio Inc. (NASDAQ: RGNX) from Overweight to Equalweight with a price target of $12.00.The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found